Plasma levels of lysophosphatidic acid in ovarian cancer versus controls: a meta-analysis

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

An international assessment of ovarian cancer incidence and mortality

(2013) Kimberly A. Lowe et al.   GYNECOLOGIC ONCOLOGY

Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer

(2012) E. Kobayashi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Serum Autotaxin is not a Useful Biomarker for Ovarian Cancer

(2012) Kazuhiro Nakamura et al.   LIPIDS

Quantifying the impact of between-study heterogeneity in multivariate meta-analyses

(2012) Dan Jackson et al.   STATISTICS IN MEDICINE

Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer

(2011) Tugan Bese et al.   Journal of Gynecologic Oncology

Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity

(2010) Feng-qiang Wang et al.   GYNECOLOGIC ONCOLOGY

Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer

(2010) Iva Sedláková et al.   TUMOR BIOLOGY